BB-101 for Treatment of Diabetic Lower Leg and Foot Ulcers

Clinical trial NCT03888053 · COMPLETED

Trial details

NCT number: NCT03888053
Sponsor: Blue Blood Biotech Corp.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetic Foot Ulcer

Start date: 2018-03-28
Primary completion: 2021-12-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.